ArticleMarine drugs2019

Pharmaceutical Development and Safety Evaluation of a GMP-Grade Fucoidan for Molecular Diagnosis of Cardiovascular Diseases.

Cédric Chauvierre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.